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Abstract Binding of the thiazolyl peptide antibiotic thiostrepton 
to the GTPase domain of 23S rRNA involves a few crucial 
nucleotides, notably A1067 (E. coif). Small RNA transcripts 
were prepared corresponding to the GTPase domain of the 
plastid 23S rRNA and the two forms of cytosolic 28S rRNAs 
found in the human malaria parasite Plasmodium falcipamm, as 
well as the plastid form of rRNA of the AIDS-related pathogen 
Toxoplasma gondii. Binding affinities of the wild type and 
mutated RNA sequences were as predicted; the malarial plastid 
sequence had by far the highest affinity, whereas that from 
toxoplasma did not bind thiostrepton. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Like plants and algae, apicomplexan parasites (malaria, 
toxoplasma etc.) carry two DNA-containing organelles, a mi-
tochondrion (mt) and a plastid (pi) [1,2]. The plastid, enve-
loped by several membranes, is vestigial and probably of an-
cient endosymbiotic origin, but it is also demonstrably active 
and could be a new target for chemotherapeutic agents [3]. 
Nucleotide (nt) sequences are available for the GTPase do-
main of the two types of 28 S rRNA specified by the nucleus 
of the human malaria pathogen Plasmodium falciparum (Pf) 
[4], as well as the pi 23S rRNA genes [6] and the 23S rRNA 
specified by the mt genome (only a partial sequence, see [5]). 
These data indicate that the high affinity binding site for the 
thiazolyl peptide antibiotic thiostrepton, A1067 in E. coli [7-
9], is conserved in the GTPase domain encoded by the plastid 
DNA, but is modified to a G in both nuclear and mitochon-
drial genomes (Fig. 1). This substitution is predicted to reduce 
rRNA binding by the antibiotic [8]. We have tested thiostrep-
ton to ascertain whether it inhibits Pf in cultures of human 
blood and have determined the levels of antibiotic binding to 
nucleus and plastid forms of Pf 28/23S rRNA. 
2. Materials and methods 
Blood cultures of the malaria parasite P. falciparum were main-
tained in vitro and the uptake of radioactive tracers in the presence 
and absence of thiostrepton was determined by methods described 
previously [10]. 
Short transcripts of wild type rRNA (corresponding to the GTPase 
domain of Pf 23S rRNApi, nt 987-1078) were transcribed in vitro 
from a PCR product that included a T7 promoter sequence in one 
of the primers. Mutated malarial rRNApi sequences (E. coli numbers 
A1067U and A1067G) were obtained by PCR methodology and tran-
scribed in the same way. Transcripts of both types of Pf 28S rRNA 
also were prepared from PCR products, in this case using either total 
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DNA or RNA as template, a reverse transcription reaction with ran-
dom primers being carried out first in the latter case. All wild type and 
modified transcript sequences were verified prior to thiostrepton bind-
ing assays. A positive control transcript was used based on the 23S 
rRNA sequence of E. coli with a mutation (U1061A) that increases 
stability and binding (kindly supplied by Dr P. Ryan, Johns Hopkins 
University, Baltimore, MD). Thiostrepton filter-binding assays were 
performed as previously described [8] except that transcripts were 
labelled with 32P and the KC1 buffer was replaced with NH4C1 [11]. 
3. Results and discussion 
Reproducible inhibition of uptake of both 
[3H]hypoxanthine and [14C]isoleucine was found with P. falci-
parum in blood cultures (50% inhibition at 3-5 uM thiostrep-
ton ml - 1 , respectively, see Fig. 2A). As shown in Fig. 2B, 
onset of inhibition of protein synthesis by thiostrepton was 
more rapid (5 h) than by tetracycline (8 h). Specificity was 
demonstrated by the lack of effect of viomycin (data not 
shown), an unrelated antibiotic that also can inhibit translo-
cation [12]. 
Evidence that the highest affinity interaction of thiostrepton 
is with 23S rRNApi was obtained from a thiostrepton filter-
binding assay [8]. Fig. 3A shows that the mutation Pfpi (E. coli 
number A1067U) markedly reduced thiostrepton binding 
(~14% of wild type). An intermediate level of binding 
(~35% of wild type) was obtained with the mutation Pfpi 
(E. coli number A1067G). Thiostrepton binding to transcripts 
corresponding to the GTPase domain (nt 1334-1427) of both 
the sporozoite and erythrocytic forms of Pf 28 S rRNA [4] 
were ~ 1 0 % of that for Pf 23S rRNApi. These data show 
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Fig. 1. Sequence of the GTPase region of the plastid 23S rRNAs of 
Plasmodium falciparum (Pf) and Toxoplasma gondii (Toxo) (numbers 
based on E. coli), showing substitution sites (circled) affecting the 
binding of thiostrepton [7]. The corresponding nucleotides in Pf cy-
tosolic 28S rRNA and Pf mitochondrial 23S rRNA are indicated. 
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Fig. 2. Thiostrepton inhibition of Plasmodium falciparum in blood cultures. A: Dose-response curve. B: Inhibition of incorporation of 
[14C]isoleucine in cultures following addition (arrow) of 10 u,M thiostrepton ml-1 (+), or 100 itM tetracycline mr 1 (o) at 23 h. Untreated con-
trol (A). 
that the nts crucial for thiostrepton binding to Pf 23S rRNA 
are as predicted from E. coli, and that the plastid form has the 
highest binding affinity. It is not yet possible to reconstruct 
the complete sequence for the GTPase domain of the 23S 
rRNAmt [5], however, the fragments of sequence available 
do not have the critical consensus nts required for thiostrep-
ton binding at positions A1067 and A1095 (E. coli numbers) 
(see Fig. 1). 
In a similar way, we tested a transcript corresponding to the 
GTPase domain of the 23S rRNApi of Toxoplasma gondii 
(Tg), a related apicomplexan that is an important opportun-
istic pathogen in patients with AIDS. In this case, the wild 
type sequence has a substitution at a different site (E. coli 
number A1077U) (see Fig. 1), that inhibits binding by thio-
strepton in E. coli [8]. This was found also to be the case with 
a transcript derived from a PCR product covering the GTPase 
domain of Tgpl 23S rRNA (nt 926-1024) (Fig. 3B). Corrective 
mutation of the Tgpi transcript (E. coli number U1077A) con-
ferred a significant increase ( X 5) in thiostrepton binding (Fig. 
3B). 
These thiostrepton binding studies constitute the first direct 
evidence that components of the malarial plastid organelle 
could be preferentially targeted by drugs. The results comple-
ment earlier studies [13,14] which inferred that toxoplasma's 
23S rRNApi might be the target of the macrolide antibiotic, 
clindamycin, acting at a different effector site. 
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Fig. 3. Thiostrepton binding curves [8] (mean of duplicates, bar = 
range). A: Short 23S transcripts of P. falciparum (Pf) wild type 
rRNAp! (O, A1067) and mutated forms (□, A1067U and A, 
A1067G), as well as Pf 28S rRNA sporozoite-type transcripts ( A ) 
and erythrocytic-type (■), compared with an optimized E. coli con-
trol transcript (•). All nucleotide numbers correspond to E. coli for 
convenience. B: T. gondii wild type rRNApi transcript ( A ) and mu-
tated transcript ( A ) compared with control transcripts from P. falci-
parum rRNApi (o) and E. coli (•). 
